Major adverse cardiovascular events and venous thromboembolism in older adults aged 50 or older with atopic dermatitis treated with oral Janus kinase inhibitors: A multicenter cohort study using TriNetX

Ezzat RZ, Paz M, Kreytak C, Senna MM. Major adverse cardiovascular events and venous thromboembolism in older adults aged 50 or older with atopic dermatitis treated with oral Janus kinase inhibitors: A multicenter cohort study using TriNetX. J Am Acad Dermatol. 2026;95(4):1135-1137.